Daubert v. Merrell Dow Pharmaceuticals

(redirected from 509 U.S. 579)
A lawsuit by brought by J. Daubert, who was born with limb-reduction defects, alleging that the cause of his disability was Bendectin, produced by Merrell Dow Pharmaceuticals
References in periodicals archive ?
(20.) See Daubert, 509 U.S. 579,595 (1993) (quoting Jack B.
Merrell Dow Pharm., Inc., 509 U.S. 579, 592 (1993) (citations omitted) ("Unlike an ordinary witness,...
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993) to be admissible."
Merrell Dow Pharm., Inc., 509 U.S. 579, 587 (1993) (citing Beech Aircraft Corp.
Merrell Dow Pharm., Inc., 509 U.S. 579, 597 (1993) (holding that judges should act as a gatekeeper in regard to the reliability of expert evidence).
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 597 (1993), the Court addressed four factors to consider in determining the admissibility of expert witness testimony.
Merrell Dow Pharm., Inc., 509 U.S. 579, 587 (1993) (abolishing standard of admissibility adopted in Frye for a more relaxed standard).
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993), an opinion that was extended to all expert testimony in a subsequent Supreme Court case and that has been specifically applied to appraisers on numerous occasions.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), augmented Frye with a number of other factors that federal courts are to consider in determining whether such information is sufficiently reliable to be admitted into evidence.
Merrell Dow Pharmaceuticals (509 U.S. 579 [1993]), which led federal trial judges to become "gatekeepers" of scientific evidence.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), together with General Electric Co.